专题：Gastrointestinal Tumor Research and Treatment

This cluster of papers focuses on the diagnosis and treatment of gastrointestinal stromal tumors (GISTs), including the efficacy and safety of targeted therapies like Imatinib Mesylate and Sunitinib, the role of PDGFRA and KIT mutations in GISTs, consensus approaches for management, surgical considerations, prognostic factors, use of EUS-guided fine needle aspiration, and the significance of succinate dehydrogenase (SDH) deficiency. It also explores the use of PET imaging for response evaluation.
最新文献
Robotic Caudate Lobectomy for a Solitary Colorectal Liver Metastasis Using Arantius‑Ligament Hanging and ICG Negative Staining

article Full Text OpenAlex

Fatal Pericarditis and Cardiac Tamponade During Selumetinib Treatment for Pericardial Neurofibroma

article Full Text OpenAlex

Association of Activating GNAS Mutations and Outcomes with Chemotherapy in Metastatic Appendiceal Adenocarcinoma

article Full Text OpenAlex

Intraperitoneal Paclitaxel-Induced Eosinophil Recruitment as a Potential Mediator of Tumor Response in Peritoneal Metastases from Gastric Cancer

article Full Text OpenAlex

Gastroenteropancreatic neuroendocrine neoplasms in children and adults: a comparative review

article Full Text OpenAlex

Universal submucosal dissection outperforms selective mucosal resection in early esophageal adenocarcinoma

article Full Text OpenAlex

«Glomus-like lesions» of the gastric fundic type mucosa — a novel endoscopic sign of autoimmune atrophic gastritis

article Full Text OpenAlex

Subregional Radiomics Analysis on Multiparametric MRI for Evaluating Lymphovascular Invasion and Survival in Gastric Cancer: A Multicenter Study

article Full Text OpenAlex

Scissor‐Type Knife Improves Trainee's Self‐Completion of Endoscopic Submucosal Dissection for Early Gastric Cancer

article Full Text OpenAlex

Long-term disease stabilization with lenvatinib in advanced thymic carcinoma: A case report

article Full Text OpenAlex

近5年高被引文献
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 1622 FWCI237.5592

Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)

article Full Text OpenAlex 1091 FWCI151.5333

Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial

article Full Text OpenAlex 722 FWCI104.2762

Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022

article Full Text OpenAlex 636 FWCI89.6737

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

article Full Text OpenAlex 537 FWCI140.8036

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial

article Full Text OpenAlex 468 FWCI122.7489

Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial

article Full Text OpenAlex 406 FWCI106.6534

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study

article Full Text OpenAlex 353 FWCI47.8819

Current developments in gastric cancer: from molecular profiling to treatment strategy

review Full Text OpenAlex 346 FWCI53.0443

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

article Full Text OpenAlex 342 FWCI76.0624